Health Trials

Role of the Immune Environment in Response to Therapy in Breast Cancer

ConditionsBreast CancerER Positive Breast CancerHER2-negative Breast CancerTNBC - Triple-Negative Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAbramson Cancer Center at Penn Medicine

About this trial

This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.

Treatment groups

No treatment groups listed

Sponsors and collaborators

Abramson Cancer Center at Penn Medicine

Lead sponsor

Source ClinicalTrials.gov